Inventiva and Sino Biopharm ink NASH deal for more than $300 M

French firm Inventiva and Chia Tai-Tianqing Pharmaceutical Group Co. (CTTQ), a subsidiary of China-based Sino Biopharm, ...

September 27, 2022 | Tuesday | News
Hong Kong fosters research and innovation on AI-driven computational imaging

The Hong Kong Polytechnic University (PolyU) has signed a cooperation agreement with Guangdong OPPO Mobile Telecommunica...

September 26, 2022 | Monday | News
China's BGI donates Huo-Yan Air Laboratory to Thailand

On September 19, 2022, Anutin Charnvirakul, Deputy Prime Minister and Minister of Public Health, Dr Satit Pitutecha, Dep...

September 20, 2022 | Tuesday | News
Menarini and SciClone ink €115 M deal to address rising prevalence of AMR in China

A. Menarini Asia-Pacific Holdings, part of The Menarini Group, and SciClone Pharmaceuticals (Holdings) have entered into...

September 21, 2022 | Wednesday | News
MGI unveils ultra high speed gene sequencer in China

China-based MGI Tech has launched DNBSEQ-G99, the latest model of the gene sequencer with mid to low range throughp...

September 20, 2022 | Tuesday | News
Advanced MedTech acquires China’s market-leader in urology

Integrated urology leader Advanced MedTech Holdings (AMTH) has announced the acquisition of a majority interest in ...

September 19, 2022 | Monday | News
Everest Medicines appoints new CEO to lead next stage of company growth

China-based Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative phar...

September 19, 2022 | Monday | News
China promotes development of new cell therapeutic drugs

China-based Biocytogen Pharmaceuticals has collaborated with FineImmune Biotechnology to co-develop cell-based therapeut...

September 16, 2022 | Friday | News
Hong Kong-based startup Great Bay Bio secures $15M funding

Great Bay Bio (GBB), Hong Kong-based startup, has announced the completion of its $15 million Pre-series B funding ...

September 15, 2022 | Thursday | News
China approves inhaled vaccine as COVID-19 booster dose

CanSino Biologics Inc has announced that the National Medical Products Administration of China (NMPA) has granted the co...

September 12, 2022 | Monday | News
Neovii & Fosun Pharma ink agreement for bringing transplantation medicine to China

Neovii Pharmaceuticals, a Swiss based global specialty-care biopharmaceutical company, and Shanghai Fosun Pharmaceutical...

September 13, 2022 | Tuesday | News
Hong Kong introduces Long COVID Chinese Medicine Rehabilitation Programme

The School of Chinese Medicine at Hong Kong Baptist University (HKBU) has launched the Everbright Care • Long COVID...

September 8, 2022 | Thursday | News
Zenas BioPharma appoints new Chief Medical Officer

Zenas BioPharma, a global biopharmaceutical company having operations in the US & China, has announced the appointme...

September 8, 2022 | Thursday | News
China's Sinovac makes progress with trivalent COVID-19 vaccine

China-based Sinovac Biotech has announced that the Chilean Public Health Institute (Instituto de Salud Pública, I...

September 7, 2022 | Wednesday | News
China approves AstraZeneca's Forxiga for CKD in patients with & without type-2 diabetes

AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in Ch...

September 6, 2022 | Tuesday | News
HitGen and Unison Medicines join hands to develop anti-infectives

Vernalis Research, a fully owned subsidiary of Chinese firm HitGen Inc., and US-based Unison Medicines Inc. have announc...

September 5, 2022 | Monday | News
China leads research of world's first spatiotemporal map of brain regeneration

A multi-institute research team led by China-based BGI Group has used BGI Stereo-seq technology to construct the world f...

September 2, 2022 | Friday | News
PharmaLex strengthens global reach and local support with offices in China

PharmaLex Group, a global service provider for the pharma, biotech and medtech industries has a...

September 1, 2022 | Thursday | News